Fragile X syndrome (FXS), the leading monogenic cause of intellectual disability and autism, results from loss of function of the RNA-binding protein FMRP. Here, we show that FMRP regulates translation of neuronal nitric oxide synthase 1 (NOS1) in the developing human neocortex. Whereas NOS1 mRNA is widely expressed, NOS1 protein is transiently coexpressed with FMRP during early synaptogenesis in layer-and region-specific pyramidal neurons. These include midfetal layer 5 subcortically projecting neurons arranged into alternating columns in the prospective Broca's area and orofacial motor cortex. Human NOS1 translation is activated by FMRP via interactions with coding region binding motifs absent from mouse Nos1 mRNA, which is expressed in mouse pyramidal neurons, but not efficiently translated. Correspondingly, neocortical NOS1 protein levels are severely reduced in developing human FXS cases, but not FMRP-deficient mice. Thus, alterations in FMRP posttranscriptional regulation of NOS1 in developing neocortical circuits may contribute to cognitive dysfunction in FXS.
INTRODUCTION
The development of neural circuits is a precisely regulated process susceptible to genetic alterations that can lead to disorders affecting the most distinctively human aspects of cognition, including speech and language, theory of mind, and complex social behavior (Geschwind and Levitt, 2007; Lui et al., 2011; Ramocki and Zoghbi, 2008; State, 2010; Walsh et al., 2008) . One such disorder, fragile X syndrome (FXS), is the leading inherited cause of intellectual disability and is often accompanied by autistic-like features, aggression, attention deficits, and delays in speech and language development (Abbeduto et al., 2007; Rogers et al., 2001; Willemsen et al., 2011) . FXS is caused by loss of function of the FMR1 gene, which encodes an RNA-binding protein (FMRP) involved in mRNA localization, stability, and translation (Ashley et al., 1993; Bagni and Greenough, 2005; Bassell and Warren, 2008; Zalfa et al., 2007) . Many FMRP mRNA targets function in synaptic development and plasticity Darnell et al., 2011) . Concordantly, Fmr1-deficient mice show neural deficits also found in patients with FXS (The Dutch-Belgian Fragile X Consortium, 1994). However, FMRP target mRNAs and their role in human neurodevelopment are not as well understood.
The study of human FMRP function may also provide insights into the molecular mechanisms and neural circuits affected in autism spectrum disorders (ASDs), which are highly comorbid with FXS (Rogers et al., 2001) . ASDs are a group of complex developmental syndromes characterized by impairments in social communication and language development, and repetitive behaviors. Multiple lines of evidence point to the dysfunction of neocortical circuits involved in social, emotional, and language processing in ASDs (Geschwind and Levitt, 2007; State, 2010; Walsh et al., 2008) . Although no overt neuroanatomical alterations have been linked to the autistic brain, there is emerging evidence of abnormal organization of cortical minicolumns (Casanova et al., 2002; Peters, 2010) , which are composed of vertically arranged neurons connected into a local network and thought to originate from developmental radial units (Mountcastle, 1997; Rakic, 1988) . Whether the molecular mechanisms altered in ASDs are associated with the development of specific human cortical circuits, including minicolumns, remains unknown.
Here, we report that FMRP binds human neuronal nitric oxide synthase 1 (NOS1, also known as nNOS) mRNA and increases its translation in the developing neocortex in a species-dependent manner. NOS1 produces the gaseous signaling molecule nitric oxide (NO), which plays important roles in the development and function of the nervous system (Bredt and Snyder, 1994; Garthwaite, 2008) . Our study of NOS1 posttranscriptional regulation was instigated by our observation of a marked discrepancy between the midfetal human neocortex expression patterns of NOS1 mRNA, which is widespread, and NOS1 protein, which is restricted to layer-and region-specific subpopulations of pyramidal neurons. These include layer 5 (L5) subcortically-projecting neurons with an alternating minicolumnar arrangement in the frontoparietal operculum (FOp) . The FOp encompasses the prospective Broca's area and orofacial motor cortex, regions involved in speech production and language comprehension (Keller et al., 2009 ). After our screen for RNA-binding proteins revealed that FMRP is abundantly bound to human NOS1 mRNA, we found that FMRP interacts with sequences in the NOS1-coding region that contain G-quartet (GQ) motifs and leads to increased NOS1 protein expression. These motifs are absent from mouse Nos1 mRNA, and replacing the GQ-containing region of human NOS1 with the mouse orthologous sequence abrogates FMRP-dependent activation of translation. Concordantly, neocortical NOS1 protein levels are dramatically reduced in human FXS, but not Fmr1-deficient mice. Thus, we identified a species-dependent posttranscriptional regulation of human NOS1 by FMRP in specific neocortical circuits during column development and synaptogenesis, and showed it to be altered in FXS.
RESULTS

NOS1 Protein Is Transiently Expressed in Developing Human Pyramidal Neurons
The current research stems from our unexpected observation that strong NADPH-diaphorase (NADPH-d) activity, a reliable histoenzymatic marker of NOS (Dawson et al., 1991; Hope et al., 1991) , is transiently present in subpopulations of pyramidal neurons in the developing human neocortex (Sestan and Kostovi c, 1994) , in addition to its previously reported localization to interneurons and cortical plate (CP) neuropil (Fertuzinhos et al., 2009; Judas et al., 1999) . Our comprehensive analysis of pre-and postnatal postmortem brains ranging from 8 postconceptional weeks (PCW) to adulthood identified transient expression of NOS1/NADPH-d in two layer-and region-specific populations of pyramidal neurons with a predominant localization to somata and apical dendrites (Figures 1A-1C ; see Figure S1A available online). Specifically, morphologically immature pyramidal neurons expressing NOS1 were present in the middle of the CP corresponding to the future L5 exclusively in the ventrolateral frontal cortex of the FOp and the dorsal part of the anterior insula starting around 15 PCW. One week later, NOS1 + pyramidal neurons were also found in the anterior cingulate cortex (ACC) and adjacent dorsolateral frontoparietal cortex in the upper CP corresponding to the future L2 and L3. NOS1 expression in both of these regions was also temporally regulated. The ACC L2/L3 expression of NOS1 was maintained at high levels throughout the late fetal ages, and decreased during early infancy (Figures 1B and S1A ; data not shown). In contrast, L5 expression of NOS1 occurred in two waves. First, the L5 expression was restricted to the FOp, and started at 15 PCW, peaked at 18-20 PCW, and was rapidly downregulated at approximately 23 PCW, after which a small number of NOS1 + pyramidal neurons were present in the ventral part of the anterior insula. Second, sparse pyramidal NOS1 expression was present throughout neocortical L5 in the weeks immediately prior to birth and was progressively downregulated after birth (Figures 1B and S1A; data not shown). Thus, in developing pyramidal neurons, NOS1 expression is precisely regulated, exhibiting temporal, laminar, and regional specificity.
Fetal L5 NOS1 + Pyramidal Neurons Form Alternating Columns
Further analysis of the midfetal FOp L5 NOS1 + pyramidal neurons revealed that they were arranged vertically into alternating arrays of intensely (NOS1 + ) and lightly (NOS1 À ) stained pyramidal neurons ( Figures 1A and 1C ) resembling previously described ontogenetic columns (Rakic, 1988) . In contrast the ACC L2/L3 NOS1 + pyramidal neurons were more densely distributed ( ) and lacked this alternating columnar arrangement ( Figure 1E ; nearest neighbor distance between cell clusters: FOp L5, 27.87 ± 5.26 mm; ACC L3, 15.75 ± 4.68 mm; p = 4.24 3 10
À9
). In contrast to midgestation, perinatal NOS1 + L5 neurons did not exhibit columnar organization ( Figure S1A ). Because the FOp is structurally and functionally lateralized (Keller et al., 2009) (18 PCW: 41, 380; and 20 PCW: 45, 150) . Although the number of NOS1 + columns was not significantly different between the left and right hemispheres (p = 0.569), the distribution of NOS1 + columns showed an asymmetric trend, peaking more rostrally in the right hemisphere, in both brains. Thus, the columnar organization of NOS1 + neurons in the midfetal FOp L5 is bilaterally present.
Molecular and Projectional Identity of NOS1 + Pyramidal
Neurons To molecularly characterize the identity of NOS1 + neurons, we examined their expression of neuronal subtype markers. In the midfetal FOp L5, markers of subcortically-projecting pyramidal neurons, BCL11B (CTIP2) and FEZF2 (FEZL, ZFP312) (Chen et al., 2005; Kwan et al., 2008; Leone et al., 2008; Molyneaux et al., 2007) , were selectively coexpressed by L5 NOS1 + neurons, forming an alternating columnar pattern identical to that of NOS1 (Figures 2A, 2B , and 2D). NOS1 + neurons also coexpressed FOXP2 ( Figure 2E ), a gene altered in a developmental disorder characterized by impaired speech and linguistic deficits (Lai et al., 2001) . In contrast, SATB2, a marker of upper-layer corticocortical pyramidal neurons (Britanova et al., 2008) Figure S2B ), confirming their upper-layer identity and distinction from the FOp L5 NOS1 + neurons. To examine whether the midfetal pyramidal neurons of diverse subtypes have distinct cytoarchitectonic arrangements, we first measured the nearest neighbor ratio (NNR) and total path length ratio (TPLR) (Buxhoeveden et al., 1996) of NOS1 + and NOS1 À L5
neurons in the 20 PCW FOp ( Figure 2C ). Figure 2H ). DiIlabeled subcortical projection neurons in the FOp formed columns similar in organization to the NOS1 + columns ( Figure 2I ).
In contrast, DiA-labeled callosal neurons in the ACC did not exhibit columnar organization ( Figure 2J ). Collectively, these results indicate that FOp NOS1 + neurons exhibit the columnar organization and molecular identity of postmigratory L5 subcortically-projecting neurons.
Transient NOS1 Expression in Pyramidal Neurons Is Concomitant with Early Synaptogenesis
Previous studies have shown that significant neocortical synaptogenesis starts during midgestation (Molliver et al., 1973) . See also Figure S1 .
Consistent with the possibility that NOS1 expression is associated with synaptogenesis, we found presynaptic synaptophysin (SYP) puncta encircling the cell membrane of FOp NOS1 + L5 neurons at the soma and apical dendrite (Figure 2F) . Our pre-embedding NOS1 immuno-EM in the 18 and 20 PCW FOp, however, revealed only sparse mature synapses in the CP ( Figures S2C and S2D Figure 2G ), suggesting that NOS1 + L5 neurons may be active. Together, these findings suggest that the expression of NOS1 in L5 FOp neurons is concomitant with early synaptogenesis and neuronal activity.
Cross-Species Comparison of Neocortical NOS1 Expression
To determine whether the spatiotemporal expression pattern of NOS1 exhibits species differences, we examined NADPHd/NOS1 expression in the gyrated macaque monkey neocortex and lissencephalic mouse neocortex ( Figure 3 ; data not shown).
In the macaque, NADPH-d + pyramidal neurons were present in L2/L3 of the ACC and adjacent frontoparietal regions, starting as early as embryonic day (E) 62, an age equivalent to human midgestation (Kostovic and Rakic, 1990) , and persisting until the late fetal period ( data not shown), indicating that pyramidal expression of NOS1 is species dependent.
Discordant NOS1 mRNA and Protein Expression Patterns in the Fetal Neocortex
To examine the expression pattern of NOS1 mRNA, adjacent tissue sections of the midfetal neocortex were analyzed with NOS1 in situ hybridization, NADPH-d, and NOS1 immunostaining ( Figure 4A) . Surprisingly, NOS1 mRNA was abundantly and widely present in the CP in all cortical layers and regions examined, including the great majority of pyramidal neurons that did not express NOS1 protein. This striking difference between the highly restricted NOS1 protein and widespread NOS1 mRNA expression suggests that NOS1 is posttranscriptionally regulated. Remarkably, Nos1 mRNA was also abundantly and widely expressed in the early postnatal mouse neocortex ( Figure 4B ). Pyramidal expression of mouse Nos1 mRNA was confirmed by quantitative RT-PCR of fluorescently sorted pyramidal neurons fate mapped in mice doubly transgenic for Emx1-Cre and a CRE-responsive Gfp (CAG-Cat-Gfp) ( Figure 4C ). Therefore, whereas NOS1 mRNA is expressed in pyramidal neurons of both human and mouse neocortex, its efficient translation into NOS1 protein occurs in subpopulations of human, but not mouse, pyramidal neurons. This indicates that pyramidal NOS1 expression is driven by species-dependent posttranscriptional regulation.
NOS1 mRNA Associates with FMRP in Human Fetal Neocortex To identify potential NOS1 mRNA-binding proteins, we used immobilized full-length human NOS1 mRNA to pull down candidate proteins from the human frontal CP at 20 and 21 PCW. To facilitate the isolation of sequence-dependent RNA-binding proteins, we used three negative control RNAs (GAPDH, EGFP, and NeoR). NOS1 mRNA-interacting proteins showed a distinct enrichment at a molecular weight of approximately 75 kDa ( Figure 5A ). To identify the protein present in this band, we analyzed our human brain transcriptome data set (http:// www.humanbraintranscriptome.org; Johnson et al., 2009; Kang et al., 2011) for RNA-binding proteins near 75 kDa that are expressed in the midfetal frontal neocortex. Analysis of four candidates (FMRP, FXR1, CPEB3, and EIF2C2) by immunoblotting of pulled-down proteins revealed that FMRP, but not the others, was strongly and specifically associated with NOS1 mRNA (Figures 5A and S4A ). The presence of FMRP in this NOS1-enriched band was confirmed by mass spectrometry (data not shown), which also revealed the putative presence of PABPC4, a poly-adenylate-binding protein, and HSPA8, a chaperone protein. Double-immunofluorescent staining showed that FMRP was highly coexpressed in NOS1 + pyramidal neurons in the midfetal FOp and ACC ( Figures 5B and S4B ). Subcellularly, FMRP and NOS1 colocalized to the soma and apical dendrite. Interestingly, most NOS1 + interneurons in the SP and CP did not express FMRP at high levels during midgestation. Together, these results suggest a potential role of FMRP in the posttranscriptional regulation of NOS1 in fetal human pyramidal neurons.
Species Differences in FMRP-NOS1 mRNA Association in the Developing Neocortex
To confirm the putative FMRP-NOS1 mRNA interaction, we performed RNA-binding protein immunoprecipitation (RIP) using 21 PCW frontal CP lysate. RNAs coimmunoprecipitated with FMRP were analyzed using quantitative RT-PCR ( Figure 5C ). Compared to rabbit immunoglobulin (IgG) control, anti-FMRP antibodies immunoprecipitated 6.8-± 0.8-fold more NOS1 mRNA, a level of enrichment similar to MAP1B mRNA (7.1-± 0.6-fold), a well known target of FMRP (Darnell et al., 2011) , and significantly higher than GAPDH mRNA (1.5-± 0.4-fold), a negative control. In contrast in the early postnatal mouse neocortex ( Figure 5D ), Nos1 mRNA was enriched only 2.7-± 0.3-fold by anti-FMRP immunoprecipitation, markedly lower than the 8.6-± 0.5-fold enrichment for Map1b mRNA and comparable to Gapdh mRNA (2.0-± 0.1-fold). Consistent with pyramidal neurons were arranged into vertical columns similar in organization to the human FOp columns (C). Strong interneuronal and weak neuropil NADPH-d staining was present in all cortical areas in mouse, macaque, and human neocortex. See also Figure S3 .
this, Nos1 was absent from the FMRP targets identified in a recent, comprehensive HITS-CLIP analysis of the mouse brain (Darnell et al., 2011) . Thus, FMRP strongly associates with human but not mouse NOS1 mRNA in the developing neocortex, suggesting that FMRP may underlie species differences in NOS1 translation.
FMRP Binds GQ-Containing Sequences in the Human NOS1-Coding Region FMRP can interact with specific mRNA sequences including GQ structures Schaeffer et al., 2001 ) and polyuridine stretches (Chen et al., 2003) . Analysis of human NOS1 mRNA revealed three putative GQ motifs and six poly-uridine stretches ( Figure 6A ). RNA pull-down assays from 21 PCW frontal CP lysate revealed that FMRP had strong affinity for each of the two NOS1-coding region GQs (GQ1 and GQ2), but not GQ3 or the U-rich regions (UR1-UR6) ( Figure 6B ). To confirm this, we synthesized a fragment of RNA representing both GQ1 and GQ2 and performed an electrophoretic mobility shift assay (EMSA; Figure 6C ). In the presence of FMRP, this RNA exhibited a significant shift that was abolished by the addition of excess nonbiotinylated ''cold'' RNA or a neutralizing FMRP antibody. To determine whether human GQ1 and GQ2 form RNA G-quadruplex structures, we used a reverse-transcription termination assay ( Figure 6D ). Reverse-transcriptase activity pauses at sites of GQ structures in a cation-dependent manner (Schaeffer et al., 2001) . Reverse transcription from both GQ1 and GQ2 RNA exhibited a significant pause at the expected GQ site in the presence of potassium, which facilitates GQ formation, but not lithium, which abrogates it. Therefore, FMRP interacts with GQ-forming sequences found within the coding region of human NOS1 mRNA.
Evolution of NOS1 mRNA GQ-Containing Sequences
To investigate whether GQ motifs are present in other mammals, we analyzed the 21 species for which NOS1 mRNA sequence was available. Highly stable tetrads at both GQ1 and GQ2 positions were predicted only in the great apes and macaque monkey ( Figure S5A ). Among great apes, which otherwise have perfectly conserved GQs, only orangutan has a point mutation that leads to a less stable two-stack GQ1 quartet, but a fully conserved GQ2 quartet. In marmoset, a New World monkey, and nonprimate mammals, with the exception of the guinea pig that exhibited one quartet, they are absent from both positions. Further analysis of the entire NOS1 coding region in nine placental mammals revealed a very high degree of conservation ( Figure S5B) , with the vast majority of substitutions being synonymous. The few nonsynonymous substitutions, however, were selectively clustered in the GQ region. This marked reduction in amino acid identity in an otherwise highly conserved protein is consistent with the hypothesis that the sequences containing the GQ motifs evolved and made possible posttranscriptional regulation by FMRP. Furthermore, these sequences have remained quite stable since their emergence in catarrhine primates, which is consistent with the expression of NOS1 in human and macaque pyramidal neurons.
FMRP Increases NOS1 Expression via Interaction with a GQ-Containing Sequence
To test the functional consequences of FMRP on NOS1 translation, we cotransfected human expression constructs of FMRP (CAG-hFMR1) and NOS1 (CAG-hNOS1) into Neuro-2a cells and quantified NOS activity ( Figure 6E ). With CAG-hFMR1 cotransfection, NOS1 activity was increased in a dose-dependent manner, by up to 3.6-± 0.9-fold (p = 0.043), indicating that (Siomi et al., 1994) was used, or when the GQ-containing sequence of the human NOS1 was replaced with the orthologous sequence from mouse Nos1 (CAG-murinized-hNOS1). Therefore, the FMRP-mediated increase in NOS1 expression is dependent on the species of the NOS1 sequence, the intact KH2 domain of FMRP, and the presence of GQ-containing sequences in the NOS1 mRNA. To specifically examine the GQ region, we cloned the NOS1 sequences containing GQ1 and GQ2 into the 3 0 UTR of SV40-GL3 and performed luciferase assays in Neuro-2a cells ( Figure 6F ). The inclusion of the human NOS1 GQs (SV40-GL3-hNOS1-GQs) led to significant dose-dependent increases in luciferase activity in response to CAG-hFMR1, indicating that FMRP increases NOS1 translation via binding to these sequences. Importantly, a mouse FMRP expression construct GATGGGGCCTCGGGTCCCGGGAATGGGCCTCA AGTGGGAGCAGAGGGGTCAAGGGAGGGGCACC GATGGGGCCTCGGGTCCCGGGAATGGGCCTCA AGTGGGAGCAGAGGGGTCAAGGGAGGGGCACC GATGGGGCCTCGGGTCCTGGGAATGGGCCTCA AGTGGGAGCAGAGGGGTCAAGGGAGGGGCACC GACAGAGTCACAGGTCTGGGTAATGGCCCTCA AGTGGGAGCAAAGCCACCAACAGAGGGGGACC GACAGGGTCCCAGGTCCCAGTAACGGACCTCA GGTGGGGGAAAAGCAGTCAACAGAGGGGGACC ** * * * * **** * ** ** ***** ***** * * ** *** ****** ***
Reverse transcription termination assay GQ1 GQ2 See also Figure S5 .
(CAG-mFmr1) dose dependently increased luciferase expression in a manner highly similar to CAG-hFMR1. However, when the human NOS1 GQ sequences were replaced with the orthologous region of the mouse Nos1 (SV40-GL3-mNos1-GQortholog), FMRP failed to enhance luciferase activity. These results indicate that FMRP activates NOS1 protein expression via binding to a sequence containing GQ motifs and that this interaction exhibits species differences. Together, these data strongly support a scenario wherein FMRP activation of NOS1 translation evolved through NOS1 nucleotide substitutions that gave rise to a GQ-containing sequence targeted by FMRP.
Mouse Pyramidal Neurons Efficiently Translate Human NOS1 in an FMRP-Dependent Manner Because mouse FMRP is able to enhance human NOS1 expression, we hypothesized that exogenous human NOS1 mRNA can be efficiently translated in mouse pyramidal neurons, likely in an Fmr1-dependent manner. To test this in vivo, we introduced a NOS1 expression construct with the CAG-Gfp reporter into mouse neocortical ventricular zone (VZ) using in utero electroporation (IUE) at E13.5 to target L5 pyramidal neurons. At P0, the majority of CAG-hNOS1-electroporated L5 pyramidal neurons expressed NOS1 protein at high levels ( Figures 7A-7C ). In contrast those electroporated with CAG-mNos1 or (D) Immunoblots of human fetal FXS and P0 mouse Fmr1 KO neocortex. Normalized to GAPDH levels, the neocortical expression of NOS1 protein was severely reduced in both human fetal FXS cases. In neonatal mouse neocortex, loss of Fmr1 did not alter neocortical NOS1 expression. See also Figure S6 .
CAG-murinized-hNOS1 expressed only low levels of NOS1 in a minority of neurons, indicating reduced protein expression efficiency consistent with our in vitro assays. Human and mouse NOS1 exhibited similar somatodendritic localization ( Figures  7A and 7B) . Therefore, our results show that mouse pyramidal neurons possess all of the cellular machinery necessary for the translation of human NOS1 protein and suggest that their diminished expression of endogenous NOS1 is a result of differences in the NOS1 mRNA sequence between human and mouse.
To assess FMRP dependence, we further electroporated Fmr1 knockout (KO) mice with CAG-hNOS1 and CAG-Gfp ( Figure 7A ). Both the number of GFP + neurons expressing NOS1 and the levels of NOS1 protein decreased significantly compared to wild-type ( Figures 7B and 7C ). In addition, neurons cultured from E14.5 Fmr1 KO and transfected with CAG-hNOS1 also exhibited a significant reduction in NOS1 levels compared to control ( Figure S6A ; 43.8% ± 7.8% reduction; p = 0.0065). These data show that FMRP is required for the efficient expression of human NOS1 protein in pyramidal neurons.
Severe Reduction in NOS1 Protein Levels in Developing Human FXS but Not Mouse Fmr1 KO Neocortex To determine whether NOS1 protein levels are altered in human FXS cases, we performed immunoblotting of neocortex from confirmed midfetal and postnatal FXS cases (15 and 18 PCW; and 9, 22, and 85 years) and age-matched controls. Neocortical lysates normalized to GAPDH levels were immunoblotted for NOS1, FMRP, and GAPDH ( Figure 7D ). Remarkably, in both fetal cases of FXS, neocortical NOS1 protein levels were severely reduced compared to matched controls. Furthermore, this deficit was age dependent, being very dramatic in the fetal cases, less so in the cases aged 9 and 22 years, and absent in the 85 years' specimen ( Figure S6C ). These results indicate that NOS1 protein expression is greatly reduced in the developing human FXS neocortex. Notably, neocortical NOS1 levels were not affected in early postnatal Fmr1 KO mice (Figures 7D and S6B) , indicating that the requirement of FMRP for NOS1 expression is species dependent.
DISCUSSION
In this study we demonstrate that human neocortical NOS1 expression is posttranscriptionally regulated by FMRP in a species-dependent manner. Molecular analyses revealed that FMRP binds GQ motif-containing sequences present in the coding region of human, but not mouse, NOS1 mRNA and facilitates NOS1 protein expression. Concordantly, NOS1 expression is severely reduced in the developing FXS human, but not FMRP-deficient mouse, neocortex. In the human neocortex, NOS1 and FMRP are transiently coexpressed during synaptogenesis in subpopulations of pyramidal neurons in regions involved in speech, language, and complex social behaviors. Together, these findings provide a novel candidate mechanism and insights into the potential connectional pathology of FXS and possibly ASD. Our analyses indicate that the FMRP-NOS1 interaction emerged as result of closely clustered nucleotide substitutions within the otherwise highly conserved coding sequence of NOS1 that gave rise to the GQ-containing motifs, occurring at the potential expense of protein integrity. FMRP binding to GQ motifs has been associated with translational repression (Bechara et al., 2009; Schaeffer et al., 2001) . There is, however, a precedent for positive, activity-dependent posttranscriptional regulation in PSD-95 (DLG4), which has an FMRP-binding GQ motif (Todd et al., 2003; Zalfa et al., 2007) . Interestingly, NOS1 and PSD-95 are functionally related. NOS1 is anchored to the synaptic membrane via a physical interaction with PSD-95 (Brenman et al., 1996) and its enzymatic product, NO, S-nitrosylates PSD-95 (Ho et al., 2011) . Although the abundant presence of NOS1 mRNA in pyramidal neurons suggests that translational regulation is involved, FMRP may also control the stability of the NOS1 transcript in a manner similar to its control of PSD-95 mRNA stability (Zalfa et al., 2007) . Furthermore, the GQ motif has been shown to mediate the dendritic localization of PSD-95 (Dictenberg et al., 2008) and may also play a role in NOS1 mRNA targeting. The possibility that NOS1 and PSD-95 are similarly regulated by FMRP is consistent with their shared postsynaptic localization, physical interaction, and related functions. The binding of FMRP to GQs has been demonstrated both in vitro (Bagni and Greenough, 2005; Bassell and Warren, 2008) and in vivo (Rackham and Brown, 2004; Iioka et al., 2011) . Recently, however, it was shown that the presence GQ motifs is not predictive of FMRP binding (Darnell et al., 2011) . Therefore, the context dependence of FMRP interactions with GQs remains to be fully elucidated, and individual potential interactions should be validated empirically.
Animal models of FXS exhibit multiple phenotypes present in human FXS, indicating that many aspects of FMRP function are well conserved. Therefore, any contribution of NOS1 to the FXS phenotype would likely involve the higher cognitive functions that are absent from mouse. This possibility is supported by the coexpression of NOS1 and FMRP in projection neurons of the FOp and the ACC and adjacent dorsal frontoparietal neocortex. The FOp encompasses the future Broca's area and its contralateral hemisphere equivalent, as well as the orofacial motor cortex, regions involved in speech production, language comprehension, and action recognition (Keller et al., 2009 ). The ACC is involved in decision making, attention, emotional processing, and social awareness (Devinsky et al., 1995) . NOS1 expression in these regions is also temporally regulated from midgestation to early infancy, a developmental period critical for early synaptogenesis, dendritic spine formation, and ingrowth of cortical afferents (Kang et al., 2011) . Therefore, the neuroanatomical localization and timing of the FMRP-NOS1 interaction are consistent with a putative role in the development of neocortical circuits, including those involved in linguistic and social functions likely affected in FXS and ASD.
This potential role of NOS1 in the development and function of human neural circuits is further supported by studies of a human NOS1 hypomorphic allele, which has been associated with attention deficit hyperactivity disorder (ADHD), impulsivity, and aggression (Reif et al., 2009) , behavioral features often comorbid with FXS (Rogers et al., 2001 ). This NOS1 hypomorphism has also been associated with hypoactivity in the ACC (Reif et al., 2009 ), a cortical region with prominent midfetal pyramidal expression of NOS1 protein. Functional imaging studies revealed a similar reduction in ACC activation in patients with FXS and ADHD during attentional-processing tasks (Bush et al., 1999; Menon et al., 2004) and in autistic children in response to a familiar face (Pierce and Redcay, 2008) . The overlapping deficits between NOS1 hypomorphism, FXS, and FXS comorbidities are consistent with a functional role of NOS1 in human brain circuitry related to FXS and ASD. Furthermore, the two midfetal neocortical regions with prominent pyramidal NOS1 expression, the ACC and FOp, exhibit highly coordinated resting state activity, suggesting functional connectivity between the two areas and the presence of a cingulo-opercular cognitive network (Power et al., 2011) . Interestingly, the connectivity of this cingulo-opercular network has been reported to be impaired in schizophrenia (Tu et al., 2012) . Remarkably, multiple sequence variations in NOS1 have been associated with schizophrenia (Cui et al., 2010; Reif et al., 2006; Shinkai et al., 2002) , supporting a potential role of NOS1 in the formation of cognitive circuits and in disorders that affect cognition.
Structural alteration in the organization of minicolumns has been reported in autism and other psychiatric disorders (Casanova et al., 2002) . In this study we found that within the midfetal FOp, alternating L5 columns coexpress FMRP and NOS1, as well as FOXP2, which is implicated in the development of speech, language, and cognition (Lai et al., 2001) , functions affected in FXS and ASD. We also showed that neurons within the same column have a shared subcortical molecular identity and connectivity. Positioned in between the columns are migratory corridors containing radial glial fibers and corticocortical projection neurons en route to the superficial layers. Thus, this fetal organization may have implications for the developmental basis of normal minicolumns (Rakic, 1988) , as well as columnopathies (Casanova et al., 2002) . Interestingly, the NOS1 + columnar neurons of the fetal FOp share some areal and projection properties with adult mirror neurons, which are present in macaque area F5 (Rizzolatti and Craighero, 2004) , an area equivalent to the human Broca's area, and project subcortical axons (Kraskov et al., 2009) . Mirror neurons, which are activated during both the observation and execution of a particular goal-directed action, are thought to contribute to theory of mind and language abilities (Rizzolatti and Craighero, 2004) , and in autistic children the mirror neuron activity that is normally observed in the FOp is absent (Dapretto et al., 2006) . Therefore, the molecular profile of NOS1 + columns, as well as their shared location and connectivity with mirror neurons, is consistent with a potential role in motor and cognitive development.
The synthesis of NO, a short-lived gas that cannot be stored or transported, must be precisely regulated and amenable to rapid, localized activation. Because FMRP controls both the dendritic localization and translation of target mRNAs, it is well suited to contribute to the dynamic regulation of NOS1 activity. It should be noted, however, that NOS1 mRNA may also be under additional, perhaps negative, posttranscription control, as suggested by the lack of NOS1 protein expression in the majority of NOS1 mRNA-expressing pyramidal neurons. The modulation of neuronal function by NO in the brain has been widely studied, and postsynaptic NO is thought to represent a retrograde signal that promotes presynaptic differentiation (Bredt and Snyder, 1994; Garthwaite, 2008) . Blockade of NOS1 function has been shown to disrupt synapse formation and result in spine loss (Nikonenko et al., 2008) . Given the potential role of NO in synapse development, the loss of NOS1 expression in the fetal FXS brain during early synaptogenesis may contribute to the dendritic spine phenotype of human FXS (Irwin et al., 2000) . Studies have also shown that NO mediates neuronal synchronization (O'Donnell and Grace, 1997) and can modulate protein function via S-nitrosylation (Jaffrey et al., 2001) , including that of histones (Nott et al., 2008) , which can mediate transcriptome changes. In future studies it will be important to characterize the mechanisms of NO function in the developing human neocortex and their potential contribution to FXS.
EXPERIMENTAL PROCEDURES Human Brain Tissue Processing
The sources and methods for the collection, dissection, and fixation of control and fragile X postmortem human tissues are described in the Extended Experimental Procedures. All specimens were collected under guidelines approved by institutional review boards and anonymized prior to our receipt. Fixed tissues were sectioned by vibratome or cryostat. For NADPH-d staining, sections were incubated in b-NADPH, nitro blue tetrazolium, and Triton X-100. Sections were preincubated in hydrogen peroxide for immunohistochemistry or directly preblocked in blocking solution for immunofluorescent staining prior to incubation with primary antibodies followed by biotinylated or fluorophore-conjugated secondary antibodies. For immunohistochemistry, sections were further incubated in avidin-biotin-peroxidase complex and visualized using DAB.
RNA Pull-Down Assay and RIP For pull-down assays, RNAs were transcribed from cDNA or PCR products, biotinylated, and captured using streptavidin beads. Human midfetal CP lysates were added, and bound proteins were analyzed by SDS-PAGE, silver staining, and immunoblotting. For RIP, FMRP-bound mRNAs were immunoprecipitated from midfetal human and neonatal mouse CP lysates and analyzed using quantitative RT-PCR.
Expression Assays and IUE
The generation of DNA constructs is described in the Extended Experimental Procedures. Neuro-2a cells were transfected by lipofection. Luciferase or NOS activity was assayed 48 hr after transfection and normalized to transfection efficiency controls. For electroporation, DNA was injected into the lateral ventricles of embryonic mice and transferred into VZ cells by 40V pulses. Electroporated brains were analyzed at P0 by immunostaining. All experiments using animals were carried out in accordance with a protocol approved by Yale University's Committee on Animal Research and National Institutes of Health guidelines.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures and six figures and can be found with this article online at doi:10.1016/j.cell. 2012.02.060.
